SCHEMBL6424231

SCHEMBL6424231

CCC[C@@](C)(C(=O)O)c1c(C)n(C(=O)c2ccc(Cl)c(Cl)c2)c2cc(F)c(O)c(F)c12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.34
AKR1C3 P42330 2/20 0.33
AKR1C2 P52895 2/20 0.33
NOTUM Q6P988 2/20 0.33
KMT2A Q03164 3/20 0.32
PTGS1 P23219 2/20 0.32
PTGS2 P35354 2/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.31
KCNH2 Q12809 1/20 0.31
CACNA1I Q9P0X4 1/20 0.31
RORC P51449 1/20 0.30
SLC6A2 P23975 1/20 0.30
SLC6A4 P31645 1/20 0.30
SLC6A3 Q01959 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HSP90AA1 P07900 1/20 0.30
HSP90AB1 P08238 1/20 0.30
MEN1 O00255 1/20 0.30
NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426836 0.95 TSHR (0.37) TSHRAKR1C3AKR1C2NOTUMKMT2A
SCHEMBL6465125 0.94 AKR1C3 (0.33) TSHRAKR1C3AKR1C2NOTUMKMT2A
SCHEMBL6423719 0.93 AKR1C3 (0.34) TSHRAKR1C3AKR1C2NOTUMKMT2A
SCHEMBL6424850 0.90 AKR1C3 (0.42) AKR1C3AKR1C2KMT2APTGS1PTGS2
SCHEMBL6428602 0.90 AKR1C3 (0.34) AKR1C3AKR1C2KMT2APTGS1PTGS2
SCHEMBL6459164 0.90 TSHR (0.33) TSHRAKR1C3AKR1C2PTGS1PTGS2
SCHEMBL6423936 0.90 ABCB11 (0.35) TSHRAKR1C3AKR1C2NOTUMKMT2A
SCHEMBL6426830 0.88 ALDH1A1 (0.36) AKR1C3AKR1C2NOTUMKMT2ALMNA
SCHEMBL6453108 0.88 AKR1C3 (0.34) AKR1C3AKR1C2KMT2APTGS1PTGS2
SCHEMBL6422809 0.87 HPGD (0.34) TSHRAKR1C3AKR1C2NOTUMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 TSHR 3525/4885AKR1C3 577/4885AKR1C2 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.